Why INT2ACT?
Advances in nucleic acid technologies and their use in addressing biological questions are essential for elucidating the fundamental molecular mechanisms of life. Each discovery from individual labs contributes to the larger picture, but real breakthroughs require coordinated collaboration. INT2ACT brings together a diverse team of researchers, each with unique expertise, to jointly develop innovative projects. I am excited to be part of this international doctoral network, which aims to drive scientific progress while also establishing a training platform for the next generation of researchers.
Dr. Dafne Campigli Di Giammartino
Supervisor of DC12
Co-supervisor of DC4 and DC14
Dr. Dafne Campigli Di Giammartino is a Tenure-track PI at the Italian Institute of Technology in Genoa, Italy.
Her research group applies cutting edge genomics and epigenetic engineering tools as well as advanced chromatin topology assays in cancer stem cells, in order to determine the role of ncRNAs and their epitranscriptional modifications in the organization of the 3D genome and gene expression regulation.
Their lab is a core component of the IIT RNA Flagship program, a collaborative effort spanning 20 IIT laboratories across Italy. They also enjoy close ties and collaborations with the Human Technopole Functional Genomics unit, including joint journal clubs/lab meetings and retreats. At the international level, they are active members of the world-wide FANTOM6 consortium, which keeps their lab connected to a vibrant research community at both national and international levels.
During most of my professional life, I worked in New York, where I developed a fascination with understanding how cells operate at the molecular level and the mechanisms that sustain cell identity, pluripotency and tumor biology. Across my career, I have been driven by a deep curiosity to understand the molecular mechanisms that govern gene expression, with the aim of revealing the fundamental rules that control this process in both physiological and pathological contexts. Only by advancing our knowledge of these basic biological principles can we manipulate underlying conditions to correct diseases and enable therapeutic interventions.
My background combines molecular biology, biochemistry and genomics. I pursued my PhD at Columbia University where I contributed to understanding the crosstalk between pre-mRNA processing and other nuclear pathways (e.g. cancer, DNA damage etc). My postdoctoral research at Weill Cornell Medicine was supported by a NYSCF fellowship and mostly focused on epigenetics and chromatin conformation, employing advanced sequencing and CRISPR technologies. Then, as a research associate at Cornell I expanded this line of research to patient-derived glioma stem cells building an atlas of 3D promoter-enhancer contacts in order to identify and target tumor-specific 3D enhancer hubs. After almost two decades abroad, I recently returned to Italy, where I established my laboratory at the Italian Institute of Technology, supported by the ECF grant from Human Technopole and the FIS2 grant from the Italian Ministry of Education.
- Breves S.*, Di Giammartino D.C.*, Nicholson J., Polyzos A., Fine H., Apostolou E. (2025) Three-dimensional regulatory hubs support oncogenic programs in glioblastoma. Molecular Cell 85:1330-1348 DOI 10.1016/j.molcel.2025.03.007
- Murphy D., Salataj E., Di Giammartino D.C., Rodriguez-Hernaez J., Kloetgen A., Garg V., Char E., Uyehara C.M., Ee L.-S., Lee U.J., Stadtfeld M., Hadjantonakis A.-K., Tsirigos A., Polyzos A., Apostolou E. (2024) 3D Enhancer–promoter networks provide predictive features for gene expression and coregulation in early embryonic lineages. Nature Structural and Molecular Biology 31: 125-140 DOI 10.1038/s41594-023-01130-4
- Di Giammartino D.C., Kloetgen A., Polyzos A., Liu Y., Kim D., Murphy D., Abuhashem A., Cavaliere P., Aronson B., Shah V., Dephoure N., Stadtfeld M., Tsirigos A., Apostolou E.(2019) KLF4 is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks. Nature Cell Biology 21: 1179-1190 DOI 10.1038/s41556-019-0390-6